Alto Neuroscience Inc.

ANRO | NYSE

Price Alert Chart Builder DCF Calculator

$30.42

-$0.21 (-0.69%)

Sep 22, 2026, 1:18 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023
Cash & Equivalents	243.73M	263.76M	176.48M	137.82M	147.59M	160.75M	168.23M	181.7M	193.12M	205.9M	82.55M	51.29M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	500K	n/a	500K	500K	500K	500K	500K	n/a	n/a	n/a
Other Long-Term Assets	838K	838K	338K	1.07M	570K	569K	4K	4K	4K	58K	131K	201K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8K	8K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.59M	5.36M	1.04M	879K	936K	23K	30K	277K	148K	150K	2.31M	117K
Total Current Assets	247.32M	269.13M	177.72M	139.45M	149.85M	163.52M	169.34M	183.53M	195.41M	208.31M	85.39M	52.05M
Property-Plant & Equipment	5.91M	6.3M	6.13M	6.49M	6.96M	7.32M	7.7M	7.58M	1.44M	1.55M	1.11M	987K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	6.75M	7.13M	6.97M	7.56M	8.03M	8.39M	8.21M	8.08M	1.95M	1.61M	1.24M	1.19M
Total Assets	254.07M	276.26M	184.69M	147.01M	157.88M	171.92M	177.54M	191.61M	197.36M	209.92M	86.63M	53.24M
Account Payables	4.02M	3.37M	1.88M	2.06M	1.67M	1.38M	1.58M	2.25M	1.84M	2.41M	1.07M	1.76M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	3.77M	2.14M	1.74M	n/a	973K	n/a	n/a	3.53M	2.32M	1.15M	n/a	n/a
Other Current Liabilities	12.88M	7.61M	2.84M	n/a	2.69M	n/a	2.61M	n/a	n/a	2.79M	n/a	185K
Total Current Liabilities	16.65M	13.12M	11.33M	9.05M	8.13M	7.26M	10.01M	14.02M	9.84M	8.01M	5.61M	5.98M
Long-Term Debt	3.28M	3.56M	18.4M	22.44M	22.12M	21.15M	11.56M	7.93M	7.74M	8.81M	9.86M	9.76M
Other Long-Term Liabilities	14.88M	16.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	142.83M	98.6M
Total Long-Term Liabilities	18.17M	19.78M	22.22M	26.4M	26.34M	25.56M	16.07M	12.54M	7.74M	8.81M	152.69M	108.35M
Total Liabilities	34.82M	32.89M	33.55M	35.45M	34.47M	32.82M	26.08M	26.56M	17.58M	16.82M	158.3M	114.33M
Total Debt	7.05M	5.69M	23.96M	27.52M	27.31M	26.44M	16.94M	16.79M	10.06M	10.01M	9.99M	9.95M
Book Value	219.25M	243.37M	151.14M	111.56M	123.41M	139.1M	151.46M	165.05M	179.78M	193.1M	-71.67M	-61.1M
Book Value Per Share	5.12	7.40	4.73	4.12	4.56	5.14	5.61	6.12	6.67	7.18	-2.67	-2.27
Common Stock	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	n/a	n/a
Retained Earnings	-255.51M	-227.87M	-201.63M	-185.45M	-171.27M	-153.57M	-138.4M	-123.2M	-106.41M	-90.38M	-76.97M	-65.75M
Comprehensive Income	17K	13K	22K	14K	31K	14K	-101K	-95K	-89K	-84K	-79K	-86K
Shareholders Equity	219.25M	243.37M	151.14M	111.56M	123.41M	139.1M	151.46M	165.05M	179.78M	193.1M	-71.67M	-61.1M
Total Investments	n/a	n/a	500K	n/a	500K	500K	500K	500K	500K	n/a	n/a	n/a